Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Yao LC, Aryee KE, Cheng M, Kaur P, Keck JG, Brehm MA. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology. Methods Mol Biol. 2019; 1953:241-252.
View in:
PubMed
subject areas
Animals
Flow Cytometry
Hematopoietic Stem Cell Transplantation
Humans
Immunity
Lymphocytes, Tumor-Infiltrating
Mice, Inbred NOD
Mice, SCID
Neoplasm Transplantation
Neoplasms
Transplantation, Heterologous
authors with profiles
Michael A Brehm PhD